This articles examines interim impacts of a disease management demonstration for Medicare fee-for-service beneficiaries also enrolled in Medicaid (dual eligibles). The study randomly assigned dual eligibles with congestive heart failure, coronary artery disease, and/or diabetes to treatment or...

Before Medicare Part D, Congress authorized the Medicare disease management demonstration to evaluate whether disease management programs—in conjunction with a comprehensive prescription drug benefit—could improve health outcomes and reduce Medicare expenditures. The demonstration...

This report evaluated Mercy Medical Center North Iowa and Health Quality Partners, two providers in the Medicare Coordinated Care Demonstration, a rigorous multiyear evaluation sponsored by the Centers for Medicare & Medicaid Services (CMS) to determine if care coordination improves quality of...

The Medicaid Buy-In program, a state Medicaid option since the late 1990s, is designed to encourage adults with disabilities to work by allowing them to buy into Medicaid when their earnings exceed standard Medicaid eligibility limits. This article describes enrollment, expenditures, and...

The new Medicare Part D benefit, which began on January 1, 2006, expanded Medicare to include prescription drugs, and it required beneficiaries to change how they interact with the program. Past experience with low enrollment in a variety of programs designed to aid low-income Medicare...